Literature DB >> 18941422

A pilot assessment of parental practices and attitudes regarding risk disclosure and clinical research involving children in Huntington disease families.

Leon S Dure1, Kimberly Quaid, T Mark Beasley.   

Abstract

PURPOSE: To characterize parental practices of informing children of risk for Huntington disease (HD), and to understand the attitudes of parents concerning childhood participation in HD research.
METHODS: An anonymous Internet survey was accessed by individuals of HD families. The survey probed for data regarding individual risk for HD, as well as when or if children had been informed of the disease. Respondents expressed their attitudes concerning childhood participation in HD clinical research.
RESULTS: Two hundred forty-nine individuals responded (approximately 80% female), and 84% had never participated in an HD clinical trial. Seventy-five percent of respondents were parents; nearly two thirds of them had provided some information about HD to their children. There was overwhelming support for affected, at-risk, and unaffected adults in terms of HD research participation, but there was a statistically significant disparity by gene status, with gene negative and symptomatic gene positive adults being more inclined to participate than at-risk or asymptomatic/gene positive adults. More than 50% of respondents supported childhood participation, but typically in late adolescence (15-18 years). Gene negative and symptomatic adults were statistically more likely to agree with childhood inclusion than at-risk or asymptomatic/gene positive adults.
CONCLUSION: These results serve as pilot data for further investigations to address childhood participation in HD research. In addition, these findings will inform ongoing studies as to appropriate practices to undertake to include minors.

Entities:  

Mesh:

Year:  2008        PMID: 18941422      PMCID: PMC3708301          DOI: 10.1097/GIM.0b013e31818adb01

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  18 in total

1.  Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers.

Authors:  G E Berrios; A C Wagle; I S Marková; S A Wagle; L W Ho; D C Rubinsztein; J Whittaker; C Ffrench-Constant; A Kershaw; A Rosser; T Bak; J R Hodges
Journal:  Psychiatry Res       Date:  2001-07-24       Impact factor: 3.222

2.  Enhancing the ethical conduct of genetic research: investigating views of parents on including their healthy children in a study on mild hearing loss.

Authors:  L Gillam; Z Poulakis; S Tobin; M Wake
Journal:  J Med Ethics       Date:  2006-09       Impact factor: 2.903

3.  Understanding the psychiatric prodrome of Huntington disease.

Authors:  Adam Rosenblatt
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09       Impact factor: 10.154

Review 4.  The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.

Authors:  Julie Leegwater-Kim; Jang-Ho J Cha
Journal:  NeuroRx       Date:  2004-01

5.  Psychiatric disorders in preclinical Huntington's disease.

Authors:  Camille L Julien; Jennifer C Thompson; Sue Wild; Pamela Yardumian; Julie S Snowden; Gwen Turner; David Craufurd
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

6.  A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease.

Authors: 
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

7.  Psychiatric symptoms in neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects.

Authors:  G E Berrios; A C Wagle; I S Marková; S A Wagle; A Rosser; J R Hodges
Journal:  Acta Psychiatr Scand       Date:  2002-03       Impact factor: 6.392

8.  Guidelines for informed consent in biomedical research involving paediatric populations as research participants.

Authors:  Dennis Gill
Journal:  Eur J Pediatr       Date:  2003-04-26       Impact factor: 3.183

9.  Ethical implications of including children in a large biobank for genetic-epidemiologic research: a qualitative study of public opinion.

Authors:  David Kaufman; Gail Geller; Lisa Leroy; Juli Murphy; Joan Scott; Kathy Hudson
Journal:  Am J Med Genet C Semin Med Genet       Date:  2008-02-15       Impact factor: 3.908

10.  Detection of Huntington's disease decades before diagnosis: the Predict-HD study.

Authors:  J S Paulsen; D R Langbehn; J C Stout; E Aylward; C A Ross; M Nance; M Guttman; S Johnson; M MacDonald; L J Beglinger; K Duff; E Kayson; K Biglan; I Shoulson; D Oakes; M Hayden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12-20       Impact factor: 10.154

View more
  1 in total

1.  Prenatal testing in Huntington disease: after the test, choices recommence.

Authors:  Hanane Bouchghoul; Stéphane-Françoise Clément; Danièle Vauthier; Cécile Cazeneuve; Sandrine Noel; Marc Dommergues; Delphine Héron; Jacky Nizard; Marcela Gargiulo; Alexandra Durr
Journal:  Eur J Hum Genet       Date:  2016-06-15       Impact factor: 4.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.